GILD vs. BIIB
Compare and contrast key facts about Gilead Sciences, Inc. (GILD) and Biogen Inc. (BIIB).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GILD or BIIB.
Key characteristics
| GILD | BIIB | |
|---|---|---|
| YTD Return | 0.61% | -20.84% |
| 1Y Return | 8.35% | -23.33% |
| 3Y Return (Ann) | 7.91% | -15.08% |
| 5Y Return (Ann) | 8.87% | -1.77% |
| 10Y Return (Ann) | 0.40% | -3.89% |
| Sharpe Ratio | 0.36 | -0.90 |
| Daily Std Dev | 24.22% | 26.01% |
| Max Drawdown | -70.84% | -90.00% |
| Current Drawdown | -10.61% | -53.28% |
Fundamentals
| GILD | BIIB | |
|---|---|---|
| Market Cap | $99.23B | $29.84B |
| EPS | $0.82 | $7.93 |
| PE Ratio | 97.20 | 25.83 |
| PEG Ratio | 0.47 | 6.24 |
| Total Revenue (TTM) | $27.80B | $9.47B |
| Gross Profit (TTM) | $21.58B | $6.80B |
| EBITDA (TTM) | $12.15B | $2.50B |
Correlation
The correlation between GILD and BIIB is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
GILD vs. BIIB - Performance Comparison
In the year-to-date period, GILD achieves a 0.61% return, which is significantly higher than BIIB's -20.84% return. Over the past 10 years, GILD has outperformed BIIB with an annualized return of 0.40%, while BIIB has yielded a comparatively lower -3.89% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
GILD vs. BIIB - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Gilead Sciences, Inc. (GILD) and Biogen Inc. (BIIB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
GILD vs. BIIB - Dividend Comparison
GILD's dividend yield for the trailing twelve months is around 3.81%, while BIIB has not paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
GILD Gilead Sciences, Inc. | 3.81% | 3.70% | 3.40% | 3.91% | 4.67% | 3.88% | 3.65% | 2.90% | 2.57% | 1.27% |
BIIB Biogen Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
GILD vs. BIIB - Drawdown Comparison
The maximum GILD drawdown since its inception was -70.84%, smaller than the maximum BIIB drawdown of -90.00%. Use the drawdown chart below to compare losses from any high point for GILD and BIIB. For additional features, visit the drawdowns tool.
Volatility
GILD vs. BIIB - Volatility Comparison
Gilead Sciences, Inc. (GILD) and Biogen Inc. (BIIB) have volatilities of 5.72% and 5.87%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Financials
GILD vs. BIIB - Financials Comparison
This section allows you to compare key financial metrics between Gilead Sciences, Inc. and Biogen Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities